DK158443C - Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre - Google Patents

Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre

Info

Publication number
DK158443C
DK158443C DK274981A DK274981A DK158443C DK 158443 C DK158443 C DK 158443C DK 274981 A DK274981 A DK 274981A DK 274981 A DK274981 A DK 274981A DK 158443 C DK158443 C DK 158443C
Authority
DK
Denmark
Prior art keywords
alfa
heterocyliclyl
7alfa
thly
arylacetamido
Prior art date
Application number
DK274981A
Other languages
Danish (da)
English (en)
Other versions
DK274981A (da
DK158443B (da
Inventor
Kazuhiro Shima
Eizo Hirai
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of DK274981A publication Critical patent/DK274981A/da
Publication of DK158443B publication Critical patent/DK158443B/da
Application granted granted Critical
Publication of DK158443C publication Critical patent/DK158443C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK274981A 1980-06-23 1981-06-22 Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre DK158443C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8578980 1980-06-23
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (3)

Publication Number Publication Date
DK274981A DK274981A (da) 1981-12-24
DK158443B DK158443B (da) 1990-05-21
DK158443C true DK158443C (da) 1990-10-08

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
DK274981A DK158443C (da) 1980-06-23 1981-06-22 Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre

Country Status (31)

Country Link
US (1) US4418058A (fr)
JP (1) JPS5711909A (fr)
KR (1) KR840000693B1 (fr)
AR (1) AR230007A1 (fr)
AT (1) AT380790B (fr)
AU (1) AU541627B2 (fr)
BE (1) BE889351A (fr)
BG (1) BG37991A3 (fr)
CA (1) CA1164801A (fr)
CH (1) CH648210A5 (fr)
CS (1) CS221835B2 (fr)
DD (1) DD159879A5 (fr)
DE (1) DE3124592A1 (fr)
DK (1) DK158443C (fr)
ES (1) ES503283A0 (fr)
FI (1) FI75490C (fr)
FR (1) FR2484835A1 (fr)
GB (1) GB2078737B (fr)
GR (1) GR75646B (fr)
HU (1) HU183494B (fr)
IE (1) IE51331B1 (fr)
IL (1) IL63136A (fr)
IT (1) IT1144812B (fr)
NL (1) NL191777C (fr)
NO (1) NO156036C (fr)
NZ (1) NZ197414A (fr)
PT (1) PT73239B (fr)
RO (1) RO82720B (fr)
SE (1) SE460702B (fr)
YU (1) YU44416B (fr)
ZA (1) ZA814203B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
BR0112417A (pt) * 2000-07-13 2003-07-01 Daiichi Seiyaku Co Composições farmacêuticas contendo composto dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (fr) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
FR2374031A1 (fr) * 1976-12-17 1978-07-13 Scherico Ltd Nouvelles formulations d'antibiotiques b-lactame, leur procede de preparation, melange antibiotique injectable ainsi que son procede de preparation
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (fr) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Mecanismes multiplicateurs d'efforts
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
RO82720A (fr) 1984-05-23
SE460702B (sv) 1989-11-13
DK274981A (da) 1981-12-24
NO156036C (no) 1987-07-15
BE889351A (fr) 1981-10-16
ES8203887A1 (es) 1982-04-01
YU44416B (en) 1990-08-31
SE8103904L (sv) 1981-12-24
IT8167863A0 (it) 1981-06-22
YU157381A (en) 1984-10-31
KR830005848A (ko) 1983-09-14
JPS6364405B2 (fr) 1988-12-12
GR75646B (fr) 1984-08-02
CS221835B2 (en) 1983-04-29
DE3124592C2 (fr) 1990-12-20
DD159879A5 (de) 1983-04-13
ES503283A0 (es) 1982-04-01
US4418058A (en) 1983-11-29
IL63136A (en) 1984-07-31
NL191777B (nl) 1996-04-01
FI75490B (fi) 1988-03-31
JPS5711909A (en) 1982-01-21
CH648210A5 (de) 1985-03-15
CA1164801A (fr) 1984-04-03
PT73239A (en) 1981-07-01
AR230007A1 (es) 1984-02-29
GB2078737A (en) 1982-01-13
FR2484835B1 (fr) 1983-07-01
DK158443B (da) 1990-05-21
FI811948L (fi) 1981-12-24
NZ197414A (en) 1984-10-19
NO812090L (no) 1981-12-28
FI75490C (fi) 1988-07-11
NL8102943A (nl) 1982-01-18
RO82720B (ro) 1984-07-30
IL63136A0 (en) 1981-09-13
IE51331B1 (en) 1986-12-10
AU541627B2 (en) 1985-01-17
AU7209781A (en) 1983-01-06
DE3124592A1 (de) 1982-02-11
KR840000693B1 (ko) 1984-05-21
IT1144812B (it) 1986-10-29
PT73239B (en) 1982-07-22
GB2078737B (en) 1984-03-14
ZA814203B (en) 1982-09-29
AT380790B (de) 1986-07-10
NO156036B (no) 1987-04-06
ATA278881A (de) 1985-12-15
NL191777C (nl) 1996-08-02
HU183494B (en) 1984-05-28
IE811347L (en) 1981-12-23
BG37991A3 (en) 1985-09-16
FR2484835A1 (fr) 1981-12-24

Similar Documents

Publication Publication Date Title
DK163243C (da) Fremgangsmaade til fremstilling af cephalosporinderivater
DK534481A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK99781A (da) Fremgangsmaade til fremstilling af carboxtyrilderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK417981A (da) Fremgangsmaade til fremstilling af 3-aryl-5-isothiazol-derivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK88081A (da) Fremgangsmaade til fremstilling af tetrazolderivater
DK95383D0 (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK319281A (da) Femgangsmaade til fremstilling af benzisoselenazoloner
DK57480A (da) Fremgangsmaade til fremstilling af insulinderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK158443C (da) Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre
DK86283D0 (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK554581A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK508881A (da) Fremgangsmaade til fremstilling af oploesninger af 7-amincophelosporansyrer
DK424781A (da) Fremgangsmaade til fremstilling af quinolonderivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK142381A (da) Fremgangsmaade til fremstilling af substituerede triarylthiazolforbindelser
DK551481A (da) Fremgangsmaade til fremstilling af triazolderivater
DK156168C (da) Fremgangsmaade til fremstilling af en vandig oploesning af calciumnitrit

Legal Events

Date Code Title Description
PUP Patent expired